FindTrial
Sign In

EVALUATION OF THE EFFECTS OF EXTENDED OXYGEN DURING RESPIRATORY REHABILITATION IN PATIENTS WITH COPD NORMOSSIEMICI - ND

EVALUATION OF THE EFFECTS OF EXTENDED OXYGEN DURING RESPIRATORY REHABILITATION IN PATIENTS WITH COPD NORMOSSIEMICI - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-011767-36-IT
Enrollment
Unknown
Registered
2009-03-25
Start date
2009-02-17
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PATIENTS WITH COPD MedDRA version: 9.1 Level: SOC Classification code 10038738

Interventions

Trade Name: OSSIGENO LIQ 26000LT Pharmaceutical Form: Inhalation gas INN or Proposed INN: Oxygen Concentration unit: l litre(s) Concentration type: equal Concentration number: 1-

Sponsors

AZIENDA OSPEDALIERA ISTITUTI CLINICI DI PERFEZIONAMENTO DI MILANO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PATIENTS WITH COPD without Hypoxia Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Hypoxia FROM PATIENTS WITH EFFORT

Design outcomes

Primary

MeasureTime frame
Main Objective: WHETHER supplementation OXYGEN CAN `IMPROVING THE CAPACITY` OF PHYSICAL EXERCISE AND QUALITY `OF LIFE IN PATIENTS WITH COPD;Secondary Objective: NOT AVAILABLE;Primary end point(s): WHETHER supplementation OXYGEN CAN `IMPROVING THE CAPACITY` OF PHYSICAL EXERCISE AND QUALITY `OF LIFE IN PATIENTS WITH COPD—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026